Novavax receives record $388m funding for COVID-19 vaccine 12-May-2020 By Ben Hargreaves CEPI awards Novavax highest investment to date, with the biotech progressing candidate into trials and partners with Emergent for production.
Pfizer and BioNTech work to scale up COVID-19 vaccine production 11-May-2020 By Ben Hargreaves Pfizer identifies four facilities globally to produce vaccine, while BioNTech will increase production at its German facilities.
Regeneron devotes New York facility to COVID-19 cocktail treatment 11-May-2020 By Ben Hargreaves Regeneron expects an antibody cocktail against coronavirus to be ready for trials in June, plans to utilize entire facility for production.
How to prevent another COVID-19? ‘Invest in infrastructure’ 06-May-2020 By Ben Hargreaves CEO of Berkeley Lights talks about the company’s work to identify antibodies against COVID-19 and what the long-term picture looks like.
Lonza and Moderna shoot for billion COVID-19 vaccine doses 05-May-2020 By Ben Hargreaves Moderna announces it has partnered with Lonza with the aim of producing one billion doses annually.
Ajinomoto to produce potential COVID-19 treatment for CytoDyn 05-May-2020 By Ben Hargreaves Ajinomoto agrees partnership to manufacture leronlimab, which is currently undergoing clinical trials for the treatment of COVID-19.
Pfizer’s $308m buy-in for Lyme disease vaccine 04-May-2020 By Ben Hargreaves Pfizer partners with Valneva to progress Phase II-stage vaccine candidate for Lyme disease.
Immunomedics closes $459m stock offering to launch drug, scale manufacture 04-May-2020 By Ben Hargreaves April saw the company add new CEO, receive approval for lead ADC drug, and launch a public offering of stock.
COVID-19 vaccine in one year ‘wishful thinking’ 04-May-2020 By Ben Hargreaves The likelihood of an effective vaccine being developed and scaled up in less than 12 months is unrealistic, suggests GlobalData analyst.
Catalent takes on manufacture of J&J’s coronavirus vaccine 30-Apr-2020 By Ben Hargreaves Catalent announces partnership with J&J to manufacture lead COVID-19 vaccine candidate, plans to hire 300 staff and manufacture 24/7.
AZ and Oxford University partner to develop coronavirus vaccine 30-Apr-2020 By Ben Hargreaves Under the agreement, AZ will develop, manufacture and distribute the vaccine that has already begun Phase I trials.
World leaders work on $8bn vaccine fund effort 28-Apr-2020 By Ben Hargreaves The WHO and world leaders commit to a fund to accelerate development of vaccines, tests and treatments for COVID-19.
AskBio buys BrainVectis for early-stage gene therapies 27-Apr-2020 By Ben Hargreaves AskBio acquires gene therapy biotech working on treatments for neurodegenerative disorders.
Takeda agrees license to strengthen plasma pipeline 27-Apr-2020 By Ben Hargreaves Takeda in global licensing agreement with ProThera to develop plasma-based therapies for inflammatory conditions.
J&J strikes CDMO deal to add capacity for COVID-19 vaccine 27-Apr-2020 By Ben Hargreaves J&J agrees a manufacturing partnership with Emergent, as it looks to hit its target of one billion doses.
